Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Speech-Language Pathology

Recognizing Symptoms and Distinguishing Mimics

At a Glance

Polymyositis causes symmetric weakness in the muscles closest to the center of the body, such as the hips and shoulders. Because it is a diagnosis of exclusion, doctors must carefully distinguish it from mimics like IBM, IMNM, and antisynthetase syndrome by tracking your specific symptom patterns.

While “true” polymyositis is rare, the physical symptoms that lead to a diagnosis are very real and can be life-altering. Understanding the specific pattern of your symptoms is the first step in helping your care team determine whether you have polymyositis or one of its “mimics” [1][2].

The Core Symptoms of Polymyositis

The hallmark of polymyositis (PM) is symmetric proximal muscle weakness. “Symmetric” means it affects both sides of the body equally, and “proximal” means it affects the muscles closest to the center of your body, such as your hips, thighs, shoulders, and neck [1].

Common signs of this weakness include:

  • Mobility Struggles: Difficulty rising from a low chair or climbing stairs [3].
  • Lifting Issues: Difficulty reaching overhead to brush your hair or put away groceries.
  • Dysphagia: A medical term for difficulty swallowing, which occurs when the muscles in the throat are affected [4]. If you experience this, asking your doctor for a referral to a speech-language pathologist can help you learn safe swallowing techniques and modify food textures.
  • Fatigue: A profound, systemic exhaustion that goes beyond feeling “tired.”

Distinguishing the “Mimics”

Because PM is a diagnosis of exclusion, doctors look for specific “clues” that might point to a different, more specific condition [2][5].

1. Inclusion Body Myositis (IBM)

IBM is the most common mimic, especially in patients over age 50. Unlike PM, IBM is often asymmetric (one side is weaker than the other) and involves distal muscles (those further from the center of the body) [6][7].

  • Key Clues: Significant thinning or “wasting” of the quadriceps (thigh muscles) and a weak grip, making it hard to open jars or button clothes [7][8]. IBM is often resistant to standard steroids [9].

2. Immune-Mediated Necrotizing Myopathy (IMNM)

IMNM is a more aggressive form of muscle disease where muscle cells die (necrosis) rapidly [10].

  • Key Clues: Very severe, rapidly progressing weakness and extremely high levels of creatine kinase (CK), an enzyme released when muscle is damaged [11][12]. It is frequently linked to statin use, though the weakness continues even after the medication is stopped [11][3].

3. Antisynthetase Syndrome (ASyS)

ASyS is a systemic “multi-organ” disease. While it causes muscle weakness, it also attacks other parts of the body [1][13].

  • Key Clues: Interstitial Lung Disease (ILD), which causes shortness of breath and a dry cough, and mechanic’s hands—thickened, cracked skin on the tips and sides of the fingers that looks like a manual laborer’s hands [14][15].

4. Dermatomyositis (DM)

Dermatomyositis can look identical to PM in terms of muscle weakness, but it is defined by its effects on the skin [16].

  • Key Clues: Distinctive rashes, including a violet-colored rash on the eyelids (heliotrope rash) or red, scaly bumps on the knuckles (Gottron papules) [16][17]. These rashes are often photosensitive, meaning they worsen with sun exposure.

Clinical Comparison Table

Feature Polymyositis (PM) IBM IMNM ASyS
Weakness Pattern Symmetric, Proximal Asymmetric, Distal Symmetric, Proximal Symmetric, Proximal
Common Age Adults Over 50 Any age Adults
Main “Clue” Diagnosis of Exclusion Grip/Thigh weakness Statin history; High CK Lung issues; Mechanic’s hands / cracked skin
Onset Subacute (Weeks/Months) Chronic (Years) Acute/Subacute Variable

By carefully tracking which muscles are weakest and noting any “extra” symptoms like skin changes or shortness of breath, you can help your doctor move toward a more precise diagnosis [18].

Common questions in this guide

What are the main symptoms of polymyositis?
The hallmark symptom is symmetric proximal muscle weakness, meaning you experience equal weakness on both sides of your body. This most often affects the muscles closest to your center, such as the hips, thighs, shoulders, and neck, causing issues with standing or lifting.
How is inclusion body myositis (IBM) different from polymyositis?
IBM usually affects adults over 50 and causes asymmetrical weakness, meaning one side is weaker than the other. Unlike polymyositis, IBM primarily weakens muscles further from the center of the body, leading to weak grip strength and thinning thigh muscles.
Why does it matter if my muscle weakness is symmetrical?
The pattern of your weakness is a major clue for your diagnosis. Symmetrical weakness typically points to polymyositis or immune-mediated necrotizing myopathy, while weakness that affects one side more than the other suggests inclusion body myositis.
What does it mean if I have rough, cracked skin on my fingers?
Thickened, cracked skin on the sides and tips of your fingers is known as 'mechanic's hands'. This symptom is a key warning sign for antisynthetase syndrome, a condition that mimics polymyositis but also attacks other parts of the body, including the lungs.
Can statin medications cause muscle weakness similar to polymyositis?
Yes, a history of taking statins is linked to a condition called immune-mediated necrotizing myopathy (IMNM). This disease causes severe muscle weakness that mimics polymyositis and continues to progress even after the statin medication is stopped.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my weakness involve my finger grip or thigh muscles (quadriceps) more than my hips and shoulders?
  2. 2.Have you noticed any skin changes, such as 'mechanic's hands' or subtle rashes on my knuckles or chest?
  3. 3.Given my history with statins, how was Immune-Mediated Necrotizing Myopathy (IMNM) ruled out?
  4. 4.Is my weakness symmetrical, or does it seem to affect one side of my body more than the other?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Where are we moving in the classification of idiopathic inflammatory myopathies?

    Tanboon J, Uruha A, Stenzel W, Nishino I

    Current opinion in neurology 2020; (33(5)):590-603 doi:10.1097/WCO.0000000000000855.

    PMID: 32852298
  2. 2

    Polymyositis is a rare and favourable outcome subtype of idiopathic inflammatory myopathy in Chinese patients.

    Sun C, Tian X, Yang H, et al.

    Clinical and experimental rheumatology 2024; (42(2)):302-308 doi:10.55563/clinexprheumatol/7v9d2x.

    PMID: 38488095
  3. 3

    Immune-mediated statin myopathy.

    Loganathan P, Oddis CV, Aggarwal R

    Expert review of clinical immunology 2016; (12(1)):33-8 doi:10.1586/1744666X.2016.1103181.

    PMID: 26515829
  4. 4

    Inclusion Body Myositis: A Late Diagnosis Case Report.

    Hernández-Rivero DA, Bazán-Rodríguez L, Cruz-Domínguez MDP, et al.

    Reumatologia clinica 2024; (20(9)):511-512 doi:10.1016/j.reumae.2024.10.002.

    PMID: 39472181
  5. 5

    The Utility of Myositis Specific Antibodies in Clinical Practice.

    Biddle K, Taylor MD, Linstead SE, Kiely PDW

    The journal of applied laboratory medicine 2022; (7(5)):1189-1201 doi:10.1093/jalm/jfac038.

    PMID: 35716140
  6. 6

    Inclusion body myositis: Correcting impaired mitochondrial and lysosomal autophagy as a potential therapeutic strategy.

    Brady S, Poulton J, Muller S

    Autoimmunity reviews 2024; (23(11)):103644 doi:10.1016/j.autrev.2024.103644.

    PMID: 39306221
  7. 7

    A Rare Case of Sporadic Inclusion Body Myositis (s-IBM).

    Acharya S, Shukla S, Kitey P, et al.

    Journal of clinical and diagnostic research : JCDR 2016; (10(1)):OD07-8 doi:10.7860/JCDR/2016/14902.7111.

    PMID: 26894112
  8. 8

    Effect of sirolimus on muscle in inclusion body myositis observed with magnetic resonance imaging and spectroscopy.

    Reyngoudt H, Baudin PY, Caldas de Almeida Araújo E, et al.

    Journal of cachexia, sarcopenia and muscle 2024; (15(3)):1108-1120 doi:10.1002/jcsm.13451.

    PMID: 38613252
  9. 9

    Systemic sclerosis associated myopathy: how to treat.

    Selva-O'Callaghan A, Guillen-Del-Castillo A, Gil-Vila A, et al.

    Current treatment options in rheumatology 2023; (9(4)):151-167 doi:10.1007/s40674-023-00206-y.

    PMID: 38737329
  10. 10

    Immune-mediated necrotizing myopathy: Unusual presentations of a treatable disease.

    Nicolau S, Milone M, Tracy JA, et al.

    Muscle & nerve 2021; (64(6)):734-739 doi:10.1002/mus.27435.

    PMID: 34617293
  11. 11

    When Statins Get Physical: A Curious Cause of Statin Myopathy.

    Patel PP, Jackson CD

    Southern medical journal 2022; (115(4)):266-269 doi:10.14423/SMJ.0000000000001379.

    PMID: 35365843
  12. 12

    Statins, myalgia, and rhabdomyolysis.

    Tournadre A

    Joint bone spine 2020; (87(1)):37-42 doi:10.1016/j.jbspin.2019.01.018.

    PMID: 30735805
  13. 13

    Integrated Diagnosis Project for Inflammatory Myopathies: An association between autoantibodies and muscle pathology.

    Suzuki S, Uruha A, Suzuki N, Nishino I

    Autoimmunity reviews 2017; (16(7)):693-700 doi:10.1016/j.autrev.2017.05.003.

    PMID: 28479486
  14. 14

    Recognition of Idiopathic Inflammatory Myopathies Underlying Interstitial Lung Diseases.

    Morina G, Sambataro D, Libra A, et al.

    Diagnostics (Basel, Switzerland) 2025; (15(3)) doi:10.3390/diagnostics15030275.

    PMID: 39941205
  15. 15

    Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.

    Laporte A, Mariampillai K, Allenbach Y, et al.

    European radiology 2022; (32(5)):3480-3489 doi:10.1007/s00330-021-08411-w.

    PMID: 35022809
  16. 16

    The value of myositis-specific autoantibodies in the diagnosis of idiopathic inflammatory myopathy and tumor risk prediction.

    Shi L, Min R, Wu Y, et al.

    The Journal of international medical research 2025; (53(8)):3000605251362969 doi:10.1177/03000605251362969.

    PMID: 40757783
  17. 17

    Association of Dermatomyositis Sine Dermatitis With Anti-Nuclear Matrix Protein 2 Autoantibodies.

    Inoue M, Tanboon J, Hirakawa S, et al.

    JAMA neurology 2020; (77(7)):872-877 doi:10.1001/jamaneurol.2020.0673.

    PMID: 32310254
  18. 18

    Idiopathic inflammatory myopathies - a guide to subtypes, diagnostic approach and treatment.

    Oldroyd A, Lilleker J, Chinoy H

    Clinical medicine (London, England) 2017; (17(4)):322-328 doi:10.7861/clinmedicine.17-4-322.

    PMID: 28765407

This page provides educational information on polymyositis symptoms and disease mimics. It is not a substitute for professional medical advice or a formal diagnosis from your healthcare provider.

Get notified when new evidence is published on Polymyositis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.